OvaScience, Inc.

9 Fourth Avenue

Waltham, Massachusetts 02451

 

December 3, 2018

 

VIA EDGAR

 

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Jeffrey Gabor

 

RE:                                                                          OvaScience, Inc.

Registration Statement on Form S-3 File No. 333-228209

Request for Acceleration of Effectiveness

 

Ladies and Gentlemen:

 

In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, OvaScience, Inc. (the “Company”) hereby requests acceleration of the effective date of the Registration Statement on Form S-3 (File No. 333-228209), as amended (the “Registration Statement”), so that it may become effective at 9:00 a.m., Washington, D.C. time on December 6, 2018, or as soon as possible thereafter.

 

The Company hereby authorizes Megan N. Gates, Esq. of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. to orally modify or withdraw this request for acceleration.

 

The Company respectfully requests that it be notified of such effectiveness by a telephone call to Ms. Gates at (617) 348-4443 and that such effectiveness also be confirmed in writing. Any questions regarding this request may be addressed to Ms. Gates.

 

 

Very truly yours,

 

 

 

OVASCIENCE, INC.

 

 

 

/s/ Jonathan Gillis

 

Jonathan Gillis

 

Senior Vice President, Finance

 

cc:

OvaScience, Inc.

 

Christopher A. Kroeger., M.D., M.B.A., President and Chief Executive Officer

 

 

 

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

 

William C. Hicks, Esq.

 

Megan N. Gates, Esq.

 

Daniel A. Bagliebter, Esq.

 

 

 

Cooley, LLP

 

Miguel J. Vega, Esq.

 

Nicole Brookshire, Esq.